ORLANDO, FL (UroToday.com) - Low tumor oxygenation (hypoxia) correlates with resistance to chemotherapeutic agents. A group of Canadian investigators have recently demonstrated that in vitro and in vivo hypoxia-inducedresistance to various anti-cancer drugs can be attenuated by manipulating nitric oxide (NO) signaling through cGMP mediated pathways.
More...